Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAVEL-1: Ilepatril in Hypertension
NCT00284128Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of ilepatril in hypertension (HTN), sponsored by Sanofi. Started Dec 2005; status: completed.
02
Drugs
ilepatril
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00284128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00284128.